Bantilingan, Lilia A.
HRN: 15-61-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2026
CEFTRIAXONE 1G (VIAL)
01/27/2026
02/03/2026
IVT
2g
OD
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: